Developer docs
API playgroundTry for free, no card

Search company profiles

Bipartisan Commission on Biodefense

Full company profile

uuid00so22q

Namestring
Bipartisan Commission on Biodefense
Legal namestring
Bipartisan Commission on Biodefense
Company typeenum
Private
Founded yearint
2014
Descriptiontext

The Bipartisan Commission on Biodefense is a privately funded, bipartisan policy advisory organization headquartered in Washington, D.C., established in 2014 (originally as the Blue Ribbon Study Panel on Biodefense, renamed in 2019). It assesses the state of U.S. biodefense and issues policy recommendations to strengthen the nation's defenses against pandemics, bioterrorism, and biological warfare. Its core products include the National Blueprint for Biodefense (36 recommendations and 185 action items), the Apollo Program for Biodefense (a 10-year initiative aimed at eliminating pandemics), B-SPAN (an interactive tool launched July 2024 mapping 500+ federal entities and 150 Congressional committees involved in biodefense), the Germ Warfare graphic novel (produced with author Max Brooks), the Biollywood Podcast, and a portfolio of special-focus reports on biodetection, critical infrastructure, and diagnostics.

The Commission's governance rests on a bipartisan roster of former high-level policymakers, currently co-chaired by former Governor Tom Ridge (first DHS Secretary) and former HHS Secretary Donna Shalala, with commissioners including former Members of Congress and senior ex-officials such as Kenneth Wainstein, Anna Eshoo, Fred Upton, Susan Brooks, Peggy Hamburg, and Raj Panjabi. Day-to-day operations are run by a small core staff led by Executive Director Dr. Asha M. George. The organization engages directly with Congressional committees through testimony and briefings, and with the Executive Branch through reports and recommendations targeting DHS, HHS, DoD, USDA, CDC, and FDA. In September 2025, the Commission joined the Atlantic Council as an initiative within the Council's Scowcroft Center for Strategy and Security, expanding its institutional platform.

The Commission does not sell products or services. It is funded almost entirely by private grants — primarily from Open Philanthropy, which has contributed over $13 million cumulatively across at least five grant cycles since 2016 — supplemented by sponsors and donors. All reports, the B-SPAN tool, podcasts, and graphic novel are distributed free of charge via the Commission's website and earned media channels. The Commission's 'customers' in an outcome sense are U.S. federal policymakers, with measurable influence on legislation and appropriations, including the National Biodefense Strategy and the Biden Administration's $88.2 billion pandemic preparedness budget.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersWashington, United States
HQ citystring
Washington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biodefense policy advisory, national security policy, pandemic preparedness, public health security, biodefense recommendations
Industry1 code
1Biothreat/Biocontainment & Select Agent Public Health Laboratories
CodeHLAJAIALPrimaryYes
NAICS code1 code
  • Environment, Conservation and Wildlife Organizations813312
Product category
Public Policy Advisory
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Private Grants and Donations
TypeData Monetisation
Description

The Commission is privately funded through grants from organizations such as Open Philanthropy. Open Philanthropy has provided multiple grants totaling over $13 million since 2016, including a $5.2 million grant and a $1.35 million grant. The Commission also accepts donations from sponsors.

biodefensecommission.org
2Donations and Sponsorships
TypeSubscription Recurring
Description

The Commission maintains a 'Support Us' page soliciting contributions and lists sponsors and donors on its website. Revenue is used to fund the Commission's operations, reports, public meetings, and public awareness campaigns.

biodefensecommission.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Bipartisan Commission on Biodefense is a privately funded policy advisory organization that conducts comprehensive assessments of the U.S. biodefense enterprise and issues recommendations to strengthen federal biodefense policy. It produces a portfolio of policy reports (including the National Blueprint for Biodefense, Apollo Program for Biodefense, and The Athena Agenda), an interactive web-based mapping tool (B-SPAN), educational media (Germ Warfare graphic novel and Biollywood Podcast), and convenes public meetings with federal officials, industry, and academia to drive legislative and executive branch action on biological threats.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • The Commission's recommendations influenced the requirement for a National Biodefense Strategy, which was signed into law by President Obama, produced by the Trump Administration, and revised by the Biden Administration.
+3 more records
Product overview1 text field

The Bipartisan Commission on Biodefense is a privately funded policy advisory organization established in 2014 that provides comprehensive assessment of U.S. biodefense efforts and issues recommendations to foster change. Rather than a unified software product, the Commission offers a portfolio of intellectual products including policy reports (National Blueprint for Biodefense with 36 recommendations), major initiatives (Apollo Program for Biodefense aiming to eliminate pandemics in 10 years), interactive tools (B-SPAN mapping federal biodefense entities), educational media (Germ Warfare graphic novel with Max Brooks, Biollywood Podcast), and ongoing publications addressing various biodefense topics.

Product and service6 records
1National Blueprint for Biodefense
CategoryPolicy Report
Description

Comprehensive policy report with 36 recommendations and 185 action items to strengthen federal policies and address gaps in national biodefense capabilities against biological incidents. It is targeted at the U.S. Congress, Executive Branch, and federal departments.

2Apollo Program for Biodefense
CategoryMajor Program / Initiative
Description

Ambitious 10-year program modeled after the Apollo moon mission, designed to eliminate pandemics and empower the nation to lead technologically in combatting all biological threats. Includes a public awareness campaign with a 30-second PSA, suggested social media content, and a digital toolkit for stakeholders.

3B-SPAN (Biodefense Strategy, Policy, and Analysis Network)
CategoryInteractive Tool
Description

First-of-its-kind interactive web-based tool mapping over 500 federal entities and 150 Congressional committees and sub-committees that comprise the nation's biodefense enterprise. Available separately for both Executive and Legislative branches. Targeted at policymakers, researchers, and the general public seeking to understand the U.S. biodefense governance structure.

4Germ Warfare: A Very Graphic History
CategoryEducational Media
Description

Engaging graphic novel developed with author Max Brooks depicting previous biological warfare events and possibilities for future threats, designed to make technical biodefense information accessible to a wide audience. Available in PDF, audio, and audiovisual formats.

5Biollywood Podcast
CategoryMedia / Podcast
Description

Podcast series examining biological weapons, accidents, and naturally occurring pandemics, featuring expert analysis and scenario exploration to make biodefense topics engaging for broad audiences.

6Bipartisan Commission on Biodefense Reports Portfolio
CategoryPublications Portfolio
Description

Collection of policy reports and special focus studies including A National Blueprint for Biodefense, Biodefense in Crisis, Saving Sisyphus (Advanced Biodetection), Insidious Scourge (Critical Infrastructure), The Athena Agenda, and Promote the Antidote (Reducing the Risk from Toxins), addressing various biodefense topics for policymakers and stakeholders.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-09-25
Description

In September 2025, the Commission joined the Atlantic Council as an initiative within the Council's Scowcroft Center for Strategy and Security. This transition positions the Commission within a major international policy institution, expanding its reach and institutional support while maintaining its bipartisan identity.

2Max Brooks (Author)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

Max Brooks, author of World War Z, partnered with the Commission to create 'Germ Warfare: A Very Graphic History' — an engaging graphic novel depicting historical biological warfare events and future possibilities. The graphic novel has been distributed as PDF, audio, and audiovisual content and won a Telly Award.

biodefensecommission.org
Strategic tierMinorTypeImplementation/ SI/ Consulting PartnerAnnounced on2020-01-01
Description

Erly Stage Studios, a British firm, designed and produced the graphic novel Germ Warfare: A Very Graphic History for the Commission, handling the creative production and design work.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Hudson Institute is a policy research organization with active programs on biosecurity and pandemic preparedness in addition to broader foreign-policy and economic work. It is comparable as a Washington-based policy body producing federal policy recommendations on biological threats.

TypeDirect peer
Description

Georgetown's Center for Global Health Science and Security conducts policy research, convenes stakeholders, and advises governments on pandemic preparedness, biosecurity, and global health governance. It overlaps with the Commission's role analyzing biodefense governance and producing recommendations for federal agencies and Congress.

TypeBroad incumbent
Description

CNAS is a bipartisan national-security think tank producing policy recommendations across defense, technology, and biosecurity. It overlaps with the Commission's bipartisan-policymaker model and its production of policy outputs targeting federal biodefense and homeland-security agendas.

TypeDirect peer
Description

The Johns Hopkins Center for Health Security is an academic policy center that produces original research, policy recommendations, and convenings on pandemics, biosecurity, and public health preparedness. It is the closest substantive peer to the Commission's biodefense advisory mission and shares a similar role advising federal policymakers on biological threats.

TypeOthers
Description

The Atlantic Council is the Commission's institutional home as of September 2025, providing venue, convening, and international-policy reach through its Scowcroft Center. It is included as an institutional partner rather than a competitor, given that the Commission operates as an initiative within it.

TypeDirect peer
Description

FAS is a nonprofit policy organization that produces technical analysis and policy recommendations on biosecurity, nuclear security, and emerging-technology risks. Its biosecurity program provides a directly comparable model of a science-driven, donor-funded advisory body shaping U.S. biological-threat policy.

TypeDirect peer
Description

NTI is a nonprofit, nonpartisan global security organization whose biosecurity program works to reduce catastrophic biological risks through policy recommendations, international convenings, and industry partnerships. It is directly comparable to the Commission as a privately funded biosecurity advisory body producing reports that shape federal and international biodefense policy.

TypeBroad incumbent
Description

CFR is an established, nonpartisan policy institution that convenes senior officials and produces reports on global health security, biosecurity, and pandemic preparedness. It overlaps with the Commission's function as a convener and policy-content producer for federal decision-makers.

TypeBroad incumbent
Description

CSIS is a major bipartisan Washington think tank with substantial work on biosecurity, health security, and global health policy alongside a broader international-security portfolio. It is comparable as a senior-policymaker-led advisory body producing recommendations for Congress and the Executive Branch.

TypeDirect peer
Description

The Brown University Pandemic Center is an interdisciplinary research and policy center focused on pandemic preparedness, biological threats, and public health response. Like the Commission, it produces policy outputs intended to inform federal biodefense strategy and convenes government and academic stakeholders.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bipartisan Commission on Biodefense

Public Policy Advisorybiodefensecommission.org

What Bipartisan Commission on Biodefense does

The Bipartisan Commission on Biodefense is a privately funded, bipartisan policy advisory organization headquartered in Washington, D.C., established in 2014 (originally as the Blue Ribbon Study Panel on Biodefense, renamed in 2019). It assesses the state of U.S. biodefense and issues policy recommendations to strengthen the nation's defenses against pandemics, bioterrorism, and biological warfare. Its core products include the National Blueprint for Biodefense (36 recommendations and 185 action items), the Apollo Program for Biodefense (a 10-year initiative aimed at eliminating pandemics), B-SPAN (an interactive tool launched July 2024 mapping 500+ federal entities and 150 Congressional committees involved in biodefense), the Germ Warfare graphic novel (produced with author Max Brooks), the Biollywood Podcast, and a portfolio of special-focus reports on biodetection, critical infrastructure, and diagnostics.

The Commission's governance rests on a bipartisan roster of former high-level policymakers, currently co-chaired by former Governor Tom Ridge (first DHS Secretary) and former HHS Secretary Donna Shalala, with commissioners including former Members of Congress and senior ex-officials such as Kenneth Wainstein, Anna Eshoo, Fred Upton, Susan Brooks, Peggy Hamburg, and Raj Panjabi. Day-to-day operations are run by a small core staff led by Executive Director Dr. Asha M. George. The organization engages directly with Congressional committees through testimony and briefings, and with the Executive Branch through reports and recommendations targeting DHS, HHS, DoD, USDA, CDC, and FDA. In September 2025, the Commission joined the Atlantic Council as an initiative within the Council's Scowcroft Center for Strategy and Security, expanding its institutional platform.

The Commission does not sell products or services. It is funded almost entirely by private grants — primarily from Open Philanthropy, which has contributed over $13 million cumulatively across at least five grant cycles since 2016 — supplemented by sponsors and donors. All reports, the B-SPAN tool, podcasts, and graphic novel are distributed free of charge via the Commission's website and earned media channels. The Commission's 'customers' in an outcome sense are U.S. federal policymakers, with measurable influence on legislation and appropriations, including the National Biodefense Strategy and the Biden Administration's $88.2 billion pandemic preparedness budget.

Bipartisan Commission on Biodefense firmographics

Firmographics
Name
Bipartisan Commission on Biodefense
Legal name
Bipartisan Commission on Biodefense
Website
https://biodefensecommission.org
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Bipartisan Commission on Biodefense industry classification

Industry
Product category
Public Policy Advisory
NAICS
Environment, Conservation and Wildlife Organizations (813312)
akta.pro primary industry
Biothreat/Biocontainment & Select Agent Public Health Laboratories (HLAJAIAL)

Keywords

  • Biodefense policy advisory
  • National security policy
  • Pandemic preparedness
  • Public health security
  • Biodefense recommendations

Where Bipartisan Commission on Biodefense is headquartered

Location

Headquarters

HQ city
Washington
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Bipartisan Commission on Biodefense business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Private Grants and Donations: The Commission is privately funded through grants from organizations such as Open Philanthropy. Open Philanthropy has provided multiple grants totaling over $13 million since 2016, including a $5.2 million grant and a $1.35 million grant. The Commission also accepts donations from sponsors.
  2. Donations and Sponsorships: The Commission maintains a 'Support Us' page soliciting contributions and lists sponsors and donors on its website. Revenue is used to fund the Commission's operations, reports, public meetings, and public awareness campaigns.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Bipartisan Commission on Biodefense product offering

Product offering

Core offering

The Bipartisan Commission on Biodefense is a privately funded policy advisory organization that conducts comprehensive assessments of the U.S. biodefense enterprise and issues recommendations to strengthen federal biodefense policy. It produces a portfolio of policy reports (including the National Blueprint for Biodefense, Apollo Program for Biodefense, and The Athena Agenda), an interactive web-based mapping tool (B-SPAN), educational media (Germ Warfare graphic novel and Biollywood Podcast), and convenes public meetings with federal officials, industry, and academia to drive legislative and executive branch action on biological threats.

Product overview

The Bipartisan Commission on Biodefense is a privately funded policy advisory organization established in 2014 that provides comprehensive assessment of U.S. biodefense efforts and issues recommendations to foster change. Rather than a unified software product, the Commission offers a portfolio of intellectual products including policy reports (National Blueprint for Biodefense with 36 recommendations), major initiatives (Apollo Program for Biodefense aiming to eliminate pandemics in 10 years), interactive tools (B-SPAN mapping federal biodefense entities), educational media (Germ Warfare graphic novel with Max Brooks, Biollywood Podcast), and ongoing publications addressing various biodefense topics.

Differentiator

Problem solved

Functional benefit

Products and services

  • National Blueprint for Biodefense Comprehensive policy report with 36 recommendations and 185 action items to strengthen federal policies and address gaps in national biodefense capabilities against biological incidents. It is targeted at the U.S. Congress, Executive Branch, and federal departments.
  • Apollo Program for Biodefense Ambitious 10-year program modeled after the Apollo moon mission, designed to eliminate pandemics and empower the nation to lead technologically in combatting all biological threats. Includes a public awareness campaign with a 30-second PSA, suggested social media content, and a digital toolkit for stakeholders.
  • B-SPAN (Biodefense Strategy, Policy, and Analysis Network) First-of-its-kind interactive web-based tool mapping over 500 federal entities and 150 Congressional committees and sub-committees that comprise the nation's biodefense enterprise. Available separately for both Executive and Legislative branches. Targeted at policymakers, researchers, and the general public seeking to understand the U.S. biodefense governance structure.
  • Germ Warfare: A Very Graphic History Engaging graphic novel developed with author Max Brooks depicting previous biological warfare events and possibilities for future threats, designed to make technical biodefense information accessible to a wide audience. Available in PDF, audio, and audiovisual formats.
  • Biollywood Podcast Podcast series examining biological weapons, accidents, and naturally occurring pandemics, featuring expert analysis and scenario exploration to make biodefense topics engaging for broad audiences.
  • Bipartisan Commission on Biodefense Reports Portfolio Collection of policy reports and special focus studies including A National Blueprint for Biodefense, Biodefense in Crisis, Saving Sisyphus (Advanced Biodetection), Insidious Scourge (Critical Infrastructure), The Athena Agenda, and Promote the Antidote (Reducing the Risk from Toxins), addressing various biodefense topics for policymakers and stakeholders.

Quantifiable outcome

  • The Commission's recommendations influenced the requirement for a National Biodefense Strategy, which was signed into law by President Obama, produced by the Trump Administration, and revised by the Biden Administration.
  • +3 more outcomes

Companies that use Bipartisan Commission on Biodefense

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Bipartisan Commission on Biodefense technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Bipartisan Commission on Biodefense partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered flagship, core and minor.

  • Atlantic Council (Scowcroft Center for Strategy and Security)flagshipStrategic or Co-development Partner · 25 September 2025In September 2025, the Commission joined the Atlantic Council as an initiative within the Council's Scowcroft Center for Strategy and Security. This transition positions the Commission within a major international policy institution, expanding its reach and institutional support while maintaining its bipartisan identity.
  • Max Brooks (Author)coreStrategic or Co-development Partner · 1 January 2020Max Brooks, author of World War Z, partnered with the Commission to create 'Germ Warfare: A Very Graphic History' — an engaging graphic novel depicting historical biological warfare events and future possibilities. The graphic novel has been distributed as PDF, audio, and audiovisual content and won a Telly Award.
  • Erly Stage StudiosminorImplementation/ SI/ Consulting Partner · 1 January 2020Erly Stage Studios, a British firm, designed and produced the graphic novel Germ Warfare: A Very Graphic History for the Commission, handling the creative production and design work.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Bipartisan Commission on Biodefense competitors and assessment

Company assessment

Broad incumbents

  • Hudson Institute: Hudson Institute is a policy research organization with active programs on biosecurity and pandemic preparedness in addition to broader foreign-policy and economic work. It is comparable as a Washington-based policy body producing federal policy recommendations on biological threats.
  • Center for a New American Security (CNAS): CNAS is a bipartisan national-security think tank producing policy recommendations across defense, technology, and biosecurity. It overlaps with the Commission's bipartisan-policymaker model and its production of policy outputs targeting federal biodefense and homeland-security agendas.
  • Council on Foreign Relations (CFR): CFR is an established, nonpartisan policy institution that convenes senior officials and produces reports on global health security, biosecurity, and pandemic preparedness. It overlaps with the Commission's function as a convener and policy-content producer for federal decision-makers.
  • Center for Strategic and International Studies (CSIS): CSIS is a major bipartisan Washington think tank with substantial work on biosecurity, health security, and global health policy alongside a broader international-security portfolio. It is comparable as a senior-policymaker-led advisory body producing recommendations for Congress and the Executive Branch.

Direct peers

  • Georgetown Center for Global Health Science and Security: Georgetown's Center for Global Health Science and Security conducts policy research, convenes stakeholders, and advises governments on pandemic preparedness, biosecurity, and global health governance. It overlaps with the Commission's role analyzing biodefense governance and producing recommendations for federal agencies and Congress.
  • Johns Hopkins Center for Health Security: The Johns Hopkins Center for Health Security is an academic policy center that produces original research, policy recommendations, and convenings on pandemics, biosecurity, and public health preparedness. It is the closest substantive peer to the Commission's biodefense advisory mission and shares a similar role advising federal policymakers on biological threats.
  • Federation of American Scientists (FAS): FAS is a nonprofit policy organization that produces technical analysis and policy recommendations on biosecurity, nuclear security, and emerging-technology risks. Its biosecurity program provides a directly comparable model of a science-driven, donor-funded advisory body shaping U.S. biological-threat policy.
  • Nuclear Threat Initiative (NTI): NTI is a nonprofit, nonpartisan global security organization whose biosecurity program works to reduce catastrophic biological risks through policy recommendations, international convenings, and industry partnerships. It is directly comparable to the Commission as a privately funded biosecurity advisory body producing reports that shape federal and international biodefense policy.
  • Brown University Pandemic Center: The Brown University Pandemic Center is an interdisciplinary research and policy center focused on pandemic preparedness, biological threats, and public health response. Like the Commission, it produces policy outputs intended to inform federal biodefense strategy and convenes government and academic stakeholders.

Others

  • Atlantic Council (Scowcroft Center for Strategy and Security): The Atlantic Council is the Commission's institutional home as of September 2025, providing venue, convening, and international-policy reach through its Scowcroft Center. It is included as an institutional partner rather than a competitor, given that the Commission operates as an initiative within it.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Bipartisan Commission on Biodefense social profiles

Digital presence

Bipartisan Commission on Biodefense financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bipartisan Commission on Biodefense leadership team

Management profile

Number of profiles

Profiles1 record

Bipartisan Commission on Biodefense funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bipartisan Commission on Biodefense M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bipartisan Commission on Biodefense

What does Bipartisan Commission on Biodefense do?

The Bipartisan Commission on Biodefense is a privately funded policy advisory organization that conducts comprehensive assessments of the U.S. biodefense enterprise and issues recommendations to strengthen federal biodefense policy. It produces a portfolio of policy reports (including the National Blueprint for Biodefense, Apollo Program for Biodefense, and The Athena Agenda), an interactive web-based mapping tool (B-SPAN), educational media (Germ Warfare graphic novel and Biollywood Podcast), and convenes public meetings with federal officials, industry, and academia to drive legislative and executive branch action on biological threats.

Is Bipartisan Commission on Biodefense a public or private company?

Bipartisan Commission on Biodefense is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Bipartisan Commission on Biodefense founded?

Bipartisan Commission on Biodefense was founded in 2014. It employs 1 to 10 people.

Where is Bipartisan Commission on Biodefense based?

Bipartisan Commission on Biodefense is headquartered in Washington, United States, in the North America region.

How does Bipartisan Commission on Biodefense make money?

Two revenue lines are on record. Private Grants and Donations are the primary driver. The others are donations and Sponsorships.

Who are Bipartisan Commission on Biodefense's main competitors?

Broad incumbents on record are Hudson Institute, Center for a New American Security (CNAS), Council on Foreign Relations (CFR) and Center for Strategic and International Studies (CSIS). Direct peers are Georgetown Center for Global Health Science and Security, Johns Hopkins Center for Health Security, Federation of American Scientists (FAS), Nuclear Threat Initiative (NTI) and Brown University Pandemic Center. Atlantic Council (Scowcroft Center for Strategy and Security) is listed as an others.

Does Bipartisan Commission on Biodefense have an API?

No public API is recorded for Bipartisan Commission on Biodefense.

What industry is Bipartisan Commission on Biodefense in?

Bipartisan Commission on Biodefense's product category is Public Policy Advisory. Its primary akta.pro industry code is HLAJAIAL, Biothreat/Biocontainment & Select Agent Public Health Laboratories. Its NAICS code is 813312.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Atlantic CouncilThe Biollywood Podcast: Doom (2005)An episode of The Biollywood Podcast, produced by the Bipartisan Commission on Biodefense at the Atlantic Council, features Asha M. George, J.T. O'Brien and Robert Bradley discussing the 2005 film Doom. The panel examines the movie's premise, in which Marines respond to a containment breach at a secret Mars facility over a weaponized "24th Chromosome" serum, and its implications for astrobiodefense, biosafety and biosecurity.Atlantic CouncilMasters of the Air: Overcoming airborne pathogens indoorsThe Bipartisan Commission on Biodefense at the Atlantic Council is holding a meeting in Washington, DC, to assess federal approaches to indoor air quality and technological advances for preventing pathogen spread. The event features speakers from various academic, governmental, and industry organizations, including ARPA-H, Harvard University, and the US Green Building Council.Atlantic CouncilTwisted sisters: Biodefense supply chains and stockpilesThe Bipartisan Commission on Biodefense at the Atlantic Council will host a meeting on December 9 to discuss vulnerabilities in global supply chains for medical countermeasures and strategic stockpiles. The event features discussions on enhancing domestic manufacturing, securing international supply lines against geopolitical risks, and rebuilding the domestic supply chain for personal protective equipment. Key topics include addressing dependencies on adversaries like China and improving distribution logistics for future biological emergencies.AxiosDetecting and defending against man-made pathogensA bipartisan commission recommended an "Apollo Program" to enhance U.S. biodefense, including against engineered viruses, with spending up to $10 billion annually. The commission urged developing techniques to distinguish natural from engineered DNA and improve attribution. It noted advances in biotechnology make deliberate attacks or lab accidents more possible.